Life Sciences Tools & Services Companies By Pb Ratio

Price To Book
Price To BookEfficiencyMarket RiskExp Return
1MTD Mettler Toledo International
3.98 K
(0.08)
 1.95 
(0.16)
2TEM Tempus AI, Class
80.57
 0.07 
 8.04 
 0.59 
3CDXC Chromadex Corp
16.98
 0.18 
 9.18 
 1.67 
4WAT Waters
14.32
 0.08 
 2.95 
 0.24 
5MEDP Medpace Holdings
11.95
 0.00 
 2.94 
 0.00 
6ILMN Illumina
10.77
 0.08 
 2.30 
 0.19 
7SHC Sotera Health Co
7.89
(0.09)
 2.46 
(0.21)
8CSBR Champions Oncology
6.77
 0.05 
 4.51 
 0.23 
9A Agilent Technologies
6.68
 0.00 
 1.63 
 0.00 
10TECH Bio Techne Corp
5.6
 0.05 
 2.35 
 0.11 
11IQV IQVIA Holdings
5.25
(0.17)
 1.86 
(0.32)
12CDXS Codexis
5.09
 0.21 
 4.05 
 0.83 
13BRKR Bruker
4.9
(0.06)
 2.68 
(0.16)
14CTOR Citius Oncology,
4.55
(0.12)
 6.53 
(0.76)
15RGEN Repligen
4.17
 0.05 
 3.10 
 0.14 
16TMO Thermo Fisher Scientific
4.07
(0.17)
 1.24 
(0.21)
17MLAB Mesa Laboratories
3.98
(0.01)
 3.49 
(0.04)
18ADPT Adaptive Biotechnologies Corp
3.92
 0.11 
 5.63 
 0.59 
19GENE Genetic Technologies
3.12
(0.13)
 1.68 
(0.22)
20QGEN Qiagen NV
2.75
(0.02)
 1.26 
(0.02)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities. Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.